Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Collins

Showing results (231-240 of 428) with videos related to

Pageof 43
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2025
Modulation of the renin-angiotensin system against COVID-19: A path forward?Serge Camelo, Waly Dioh, J Pedro Teixeira, et al.
Journal of Clinical Medicine|September 12, 2017
Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart FailureSean P Collins, Michael Thorn, Richard M Nowak, et al.
Cureus|August 24, 2016
The Impact of Obesity on Patient Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate CancerHarsha Koneru, Robyn Cyr, Li Rebekah Feng, et al.
Trauma Surgery & Acute Care Open|December 13, 2021
Exception from informed consent trials: social-media-based community consultation campaigns are representative of target communitiesPaige Farley, Shannon W Stephens, Brandon Crowley, et al.
American Journal of Clinical Oncology|August 30, 2014
Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic AdenocarcinomaMarie K Gurka, Christine Kim, Aiwu Ruth He, et al.
Radiation Oncology (London, England)|April 19, 2015
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancerMarie K Gurka, Leonard N Chen, Aditi Bhagat, et al.
Cancer|December 22, 2016
Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancerRobert T Dess, William C Jackson, Simeng Suy, et al.
Frontiers in Oncology|November 7, 2014
Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancerZaker Rana, Robyn A Cyr, Leonard N Chen, et al.
Frontiers in Oncology|June 1, 2016
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose ReductionMichael C Repka, Shan Guleria, Robyn A Cyr, et al.
Frontiers in Oncology|April 8, 2024
Prognostic utility of biopsy-based <i>PTEN</i> and <i>ERG</i> status on biochemical progression and overall survival after SBRT for localized prostate cancerMichael C Repka, Tamir Sholklapper, Alan L Zwart, et al.
Pageof 43

Showing results (231-240 of 428) with videos related to

Sort By:
Pageof 43
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2025
Modulation of the renin-angiotensin system against COVID-19: A path forward?Serge Camelo, Waly Dioh, J Pedro Teixeira, et al.
Journal of Clinical Medicine|September 12, 2017
Feasibility of Serial 6-min Walk Tests in Patients with Acute Heart FailureSean P Collins, Michael Thorn, Richard M Nowak, et al.
Cureus|August 24, 2016
The Impact of Obesity on Patient Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate CancerHarsha Koneru, Robyn Cyr, Li Rebekah Feng, et al.
Trauma Surgery & Acute Care Open|December 13, 2021
Exception from informed consent trials: social-media-based community consultation campaigns are representative of target communitiesPaige Farley, Shannon W Stephens, Brandon Crowley, et al.
American Journal of Clinical Oncology|August 30, 2014
Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic AdenocarcinomaMarie K Gurka, Christine Kim, Aiwu Ruth He, et al.
Radiation Oncology (London, England)|April 19, 2015
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancerMarie K Gurka, Leonard N Chen, Aditi Bhagat, et al.
Cancer|December 22, 2016
Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancerRobert T Dess, William C Jackson, Simeng Suy, et al.
Frontiers in Oncology|November 7, 2014
Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancerZaker Rana, Robyn A Cyr, Leonard N Chen, et al.
Frontiers in Oncology|June 1, 2016
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose ReductionMichael C Repka, Shan Guleria, Robyn A Cyr, et al.
Frontiers in Oncology|April 8, 2024
Prognostic utility of biopsy-based <i>PTEN</i> and <i>ERG</i> status on biochemical progression and overall survival after SBRT for localized prostate cancerMichael C Repka, Tamir Sholklapper, Alan L Zwart, et al.
Pageof 43